In the last few years, infections caused by dermatophytes along with a concomitant increase in the number of difficult to treat cases have increasingly been recognised, indicating that dermatophytosis remains a challenging public health problem. The majority of infections are caused by Trichophyton rubrum and Trichophyton mentagrophytes complex. Terbinafine, an allylamine antifungal used orally and topically is considered to be a first-line drug in the therapy of dermatophyte infections. Terbinafine resistance has been predominately attributed to point mutations in the squalene epoxidase (SQLE) target gene a key enzyme in the ergosterol biosynthetic pathway leading to single amino acid substitutions. Here, we report the largest series of 20 terbinafine-resistant Trichophyton interdigitale isolates obtained predominately from cases of tinea corporis/cruris in three hospitals in Delhi, India exhibiting elevated MICs (4 to ≥32 μg/mL) to terbinafine and all harbouring single-point mutations Leu393Phe or Phe397Leu in the SQLE gene. In 12 (60%) T. interdigitale isolates, the Phe397Leu substitution was observed, whereas in the remaining 8 (40%) isolates the substitution Leu393Phe was reported for the first time in T. interdigitale. Furthermore, 10 susceptible T. interdigitale isolates (0.125-2 μg/mL) had a wild-type genotype.
Summary
In the last few years, infections caused by dermatophytes along with a concomitant increase in the number of difficult to treat cases have increasingly been recognised, indicating that dermatophytosis remains a challenging public health problem. The majority of infections are caused by Trichophyton rubrum and Trichophyton mentagrophytes complex. Terbinafine, an allylamine antifungal used orally and topically is considered to be a first-line drug in the therapy of dermatophyte infections. Terbinafine resistance has been predominately attributed to point mutations in the squalene epoxidase (SQLE) target gene a key enzyme in the ergosterol biosynthetic pathway leading to single amino acid substitutions. Here, we report the largest series of 20 terbinafine-resistant Trichophyton interdigitale isolates obtained predominately from cases of tinea corporis/cruris in three hospitals in Delhi, India exhibiting elevated MICs (4 to ≥32 μg/mL) to terbinafine and all harbouring single-point mutations Leu393Phe or Phe397Leu in the SQLE gene. In 12 (60%) T. interdigitale isolates, the Phe397Leu substitution was observed, whereas in the remaining 8 (40%) isolates the substitution Leu393Phe was reported for the first time in T. interdigitale. Furthermore, 10 susceptible T. interdigitale isolates (0.125-2 μg/mL) had a wild-type genotype.
Remarkably, considerably high terbinafine resistance rate of 32% was observed among 63 T. interdigitale isolates identified by sequencing of the internal transcribed spacer region. This high level of terbinafine resistance of Indian dermatophyte isolates is worrisome warranting antifungal susceptibility testing and mutation analysis for monitoring this emerging resistance.
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| INTRODUC TI ON
Dermatophytosis is the most common fungal infections in the world affecting a large proportion of the population especially in tropical and subtropical regions. 1 In recent years, increase in the incidence of infections caused by dermatophytes along with a concomitant increase in the number of difficult to treat cases indicate that dermatophytosis remains a challenging public health problem. 2 The majority of skin (tinea corporis and cruris) and nail infections worldwide are caused by two important species of dermatophytes namely,
Trichophyton rubrum and Trichophyton mentagrophytes complex. [3] [4] [5] Terbinafine (TRB), an allylamine antifungal is widely used, both orally and topically and is considered to be a first-line drug in the therapy of dermatophyte infections. 6 The drug inhibits squalene epoxidase The patients enrolled were predominately of tinea corporis/ cruris (n = 56) followed by tinea capitis (n = 10) and onychomycosis (n = 1). Skin scrapings (n = 56), hair (n = 10), and nail clippings (n = 1) were processed for direct microscopic examination by 10% potassium hydroxide (KOH)/Blankophor. The specimens were inoculated on two sets each of Sabouraud's dextrose agar (SDA) containing gentamicin and chloramphenicol and the other containing cycloheximide (0.05%) incubated at 28°C for 2 weeks.
Preliminary macroscopic phenotypic identification was done on potato dextrose agar (PDA) incubated at 28°C for 14 days. Slide cultures prepared on PDA and mounted in lactophenol cotton blue were examined microscopically.
| Molecular identification and phylogenetic analysis
Molecular identification of isolates was performed by sequenc- 
| Antifungal susceptibility testing (AFST)
Antifungal susceptibility testing (AFST) was carried out using the Clinical and Laboratory Standards Institute broth microdilution method (CLSI-BMD), using the M38-A2 guidelines. 20 The isolates were grown for 7 days on PDA at 28°C and conidial inoculum was endpoints for all the drugs were defined as the lowest concentration that produced complete inhibition of growth as read visually at 72 hours.
| Squalene epoxidase (SQLE) gene sequencing of T. interdigitale
The amplification primers for SQLE gene, that is, TrSQLE-F1,5′-ATGGTTGTAGAGGCTCCTCCC-3′ TrSQLE-R1, 5′-CTAGCTTTGAA GTTCGGCAAA-3′ as described previously were used. 16 
| In vitro susceptibility testing and SQLE gene analysis
The in vitro antifungal susceptibility profiles of Trichophyton species are summarised in Table 1 (n = 30) of isolates were resistant (MIC range: 32 to ≥64 μg/mL).
However, VRC (GM MIC: 0.32 μg/mL) and ITC (GM MIC: 0.51 μg/ mL) showed good activity. Furthermore, 21% (n = 13) and 11%
(n = 7) isolates of T. interdigitale had high MICs of ITC (MIC ≥2 μg/ mL) and VRC (MIC ≥2 μg/mL), respectively. Notably, five (8%) isolates were multi-triazole resistant including FLU (MIC ≥64 μg/mL), VRC (MIC ≥2 μg/mL), and ITC (MIC ≥2 μg/mL). Overall, among imidazoles LUZ showed excellent activity (GM MIC: 0.014 μg/ mL) against all T. interdigitale isolates. The remaining imidazoles tested, that is, SER (GM: 2.3 μg/mL), MCZ (GM: 2.4 μg/mL), CLT (GM: 2.83 μg/mL), and KTC (GM: 1.37 μg/mL) showed reduced susceptibility. For SER, 63% (n = 40) of isolates had low MICs (≤2 μg/mL), whereas 37% (n = 23) had high MICs ranging from 4 to ≥16 μg/mL. Also, GRE showed no activity (modal MIC: 4 μg/mL) and 98% isolates showed MICs ≥2 μg/mL. Overall, 75% (n = 15) of TRB-resistant T. interdigitale isolates were cross-resistant to SER (MICs ≥2 μg/mL). A total of 30 T. interdigitale isolates including 20 exhibiting high MICs of TRB (4 to ≥32 μg/mL) and 10 with low MICs of 0.125-2 μg/mL were subjected to SQLE gene sequencing.
Two important previously recognised amino acid substitutions in
T. rubrum, that is, Leu393Phe or Phe397Leu were found in SQLEp of all the TRB-resistant (4 to ≥32 μg/mL) T. interdigitale isolates, whereas the wild-type genotype was noted in 10 TRB susceptible isolates (MIC range: 0.125-2 μg/mL). In 12 (60%) T. interdigitale isolates, amino acid substitution Phe397Leu was observed, whereas in the remaining 8 (40%) isolates amino acid substitution Leu393Phe was noted (Table 2 ). substitutions may cause conformational changes in the enzyme that result in reduced drug affinity.
| D ISCUSS I ON

17,24
In the present study, 20 the present study were resistant to the commonly used five drugs (TRB MICs: >2 μg/mL, ITC MICs: ≥2 μg/mL, VRC MICs: ≥2 μg/mL, SER MICs: ≥2 μg/mL and GRE MICs: ≥4 μg/mL), 5% (n = 3) resistant to four drugs (TRB, ITC, SER and GRE) and 21% (n = 13) were resistant to three drugs used for treatment of dermatophytosis, that is, TRB, SER and GRE. Furthermore, topical CLT and MCZ also showed reduced susceptibility to T. interdigitale isolates although both drugs are still used in many public-sector hospitals in India, due to their low cost (Table 1) . Interestingly, most of the TRB-resistant T. rubrum strains reported previously showed good in vitro susceptibility to other antifungal agents tested including FLU, ITC, VRC and MCZ using agar diffusion and broth microdilution methods indicating no cross-resistance with the triazoles and imidazoles. 13, 25 However, in the present study, 55% (n = 11) of TRB-resistant T. interdigitale isolates were cross-resistant to FLU and SER and 20% (n = 4) were cross-resistant to ITC, FLU and SER which demonstrates high antifungal cross-resistance in Indian T. interdigitale isolates. This increase in resistance which is of paramount concern is possibly attributed to wide over-the-counter availability and rampant use of topical steroid and antifungal combinations by the patients themselves or by unrestricted prescription.
2
In previous studies, acquired resistance to TRB in isolates harbouring mutations in the SQLE gene in T. rubrum has not been reported. 13, 26, 27 However, recently, Yamada et al. 16 reported probable acquired resistance in 8 of the 17 patients harbouring a TRBresistant Trichophyton isolate that had already been treated with TRB when the skin and/or nail sample was sent to the laboratory for mycological analysis. Furthermore, one patient was apparently not pretreated. 16 The treatment with TRB involves a prolonged exposure to the antifungal drug, which could favour the selection of resistant strains. In the present study, none of our patients was pretreated with TRB when they were recruited in the study and all the samples were sent before commencing antifungal therapy, which suggests that primary resistance may be likely. Although it cannot be ruled out that many patients may self-treat before reporting to hospital. It is also speculated that de novo TRB-resistant strains once selected may be transmitted rapidly to close contacts. However, prospective studies on molecular typing of primary resistant strains and those developing during long-term treatment may indicate the emergence of TRB-resistant strains. Finally, the high level of TRB resistance in Indian dermatophyte isolates is worrisome warranting antifungal susceptibility testing and mutation analysis for detection of emerging resistance.
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